Advancing Science. Improving Patient Care.
Stay informed with the latest clinical research, regulatory updates, and scientific developments across key therapeutic areas. Kaizen Pharmaceuticals' Global Research platform provides healthcare professionals with concise, evidence-based summaries of significant international studies, clinical trials, treatment advances, and regulatory decisions that shape modern healthcare.
FDA Approves Palbociclib for Maintenance Treatment in HR+/HER2+ Breast Cancer
Regulatory update summarizing the Phase III PATINA trial and FDA decision on palbociclib maintenance therapy alongside HER2-directed and endocrine treatment.
Latest Global Research
No research found for this selection.
Try a different search term or therapeutic area.
Scientific Information Notice
The Global Research section provides concise summaries of publicly available scientific publications, clinical research, treatment guidelines, and regulatory updates from recognized international organizations and peer-reviewed sources.
Unless specifically stated, the research featured in this section has not been conducted, sponsored, funded, or endorsed by Kaizen Pharmaceuticals.